DJIA 17,293.76 27.77 0.16%
NASDAQ 4,584.03 -9.39 -0.20%
S&P 500 2,010.10 -1.26 -0.06%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

42.05 0.17 (0.41%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ISIS $42.05 0.41%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $41.96
Previous Close $41.88
Daily Range $41.75 - $42.66
52-Week Range $22.25 - $62.66
Market Cap $5.0B
P/E Ratio -51.70
Dividend (Yield) $0.00 (0.0%)
Volume 1,076,549
Average Daily Volume 2,116,812
Current FY EPS -$0.70

Sector

Healthcare

Industry

Drugs

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website: http://www.isispharm.com/

News & Commentary Rss Feed

Why ISIS Pharmaceuticals Inc. Stock Is Flat in 2014

ISIS Pharmaceuticals shares have rebounded since spring, but still remain unchanged this year as investors digest a big stock move last year and wait for further proof that antisense RNA technology has blockbuster potential.

Jim Cramer's Top Stock Picks: ISIS DDD CY

Isis Pharmaceuticals Earns $4M from Achaogen For The Initiation Of A Phase 3 Study Of Plazomicin

Why Anxious Investors' Pressure Could Push Small Cap Stocks Lower

Isis Pharmaceuticals (ISIS) Weak On High Volume Today

Jim Cramer's Top Stock Picks: TWTR TASR ACAD ISIS RH

Trade-Ideas: Isis Pharmaceuticals (ISIS) Is Today's Post-Market Leader Stock

October 31st Options Now Available For Isis Pharmaceuticals (ISIS)

'Mad Money' Lightning Round: Buy, Buy, Buy Flextronics

Notable ETF Inflow Detected - IWM, ISIS, GPK, ULTI

See More ISIS News...

ISIS's Top Competitors

ISIS $42.05 (0.41%)
Current stock: ISIS
AMGN $143.51 (1.05%)
Current stock: AMGN
GILD $105.92 (-0.01%)
Current stock: GILD
BIIB $328.76 (-0.37%)
Current stock: BIIB